Thursday, November 19, 2015 6:39:24 PM
LECTURE
•Plasmid IL-12 Electroporation in Melanoma
•
Provider Statement: This continuing medical education activity is provided by Vindico Medical Education.
Support Statement: This activity is supported by an educational grant from Merck and Co., Inc.
Target Audience: The intended audience for the activities is medical oncologists, surgical oncologists, dermatologists, oncology nurses, nurse practitioners, physician assistants and other healthcare professionals involved in the treatment of patients with melanoma.
Learning Objectives: Upon successful completion of this educational activity, participants should be better able to assess the value of plasmid IL-12 electroporation in treating patients with advanced melanoma.
Faculty:
Alain Algazi, MD
Assistant Professor
UCSF Melanoma Oncology
UCSF Helen Diller Family
Comprehensive Cancer Center
San Francisco, California
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM